Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9Q5V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,154
Award facts
- Contract value 100% obligated
- $16,154.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,154.25 for XELJANZ XR 11 MG tablets (30-count units) by the Defense Logistics Agency on January 6, 2026. The contract utilizes firm fixed-price pricing with an ultimate completion date of January 7, 2026, and was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and runs through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
The parent entity, Cencora, Inc. (doing business as AmerisourceBergen), holds the primary indefinite delivery contract with the Defense Logistics Agency valued at up to $999,999,999.00 through December 2031. This arrangement enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare systems, and other federal medical institutions worldwide. The delivery of XELJANZ XR—a prescription medication used to treat rheumatoid arthritis and other inflammatory conditions—represents routine pharmaceutical procurement fulfilling military healthcare requirements through this established contract vehicle.
Quick answers
Who was awarded contract SPE2DR26F9Q5V?
SPE2DR26F9Q5V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F9Q5V worth?
The government has obligated $16,154 on SPE2DR26F9Q5V.
Is contract SPE2DR26F9Q5V an order under another contract?
Yes. SPE2DR26F9Q5V is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9Q5V competed?
The extent of competition for SPE2DR26F9Q5V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award